SEHK:1258
SEHK:1258Metals and Mining

Can Management Changes at China Nonferrous Mining (SEHK:1258) Reshape Its Growth Story?

China Nonferrous Mining Corporation Limited recently announced that Mr. Yaoyu Tan resigned as non-executive director and audit committee member, with Mr. Zhijiang Chen, a senior accountant with extensive financial management experience within the company’s group, appointed as his replacement effective October 28, 2025. In addition, the company released operating results and earnings guidance for the first nine months of 2025, highlighting a significant increase in copper cathode production...
SEHK:2333
SEHK:2333Auto

How Investors May Respond To Great Wall Motor (SEHK:2333) Expanding Dual Inverter Partnership With BorgWarner

On October 30, 2025, BorgWarner announced it will expand its partnership with Great Wall Motor by launching two additional electrified propulsion projects utilizing advanced dual inverter technology, with mass production targeted for 2026. This collaboration provides Great Wall Motor with greater flexibility and efficiency in hybrid and plug-in hybrid development, supporting regulatory compliance and quicker product iterations for the competitive Chinese automotive market. We'll explore how...
SEHK:175
SEHK:175Auto

Is Geely a Bargain After 8% Pullback and Global EV Expansion Headlines?

Wondering if Geely Automobile Holdings is really a bargain or just looks like one? Let’s break down what’s driving its current price and see if there’s a hidden opportunity for investors like you. Geely’s shares have powered ahead with a 24.4% gain so far this year and are up 22.7% over the last 12 months, but have recently pulled back by around 8% in the past month. This might catch the attention of value hunters or raise questions about changing risks. This recent price drop comes on the...
SEHK:2162
SEHK:2162Biotechs

Why Is Keymed Biosciences (SEHK:2162) Drawing Big-Name Support After Stapokibart’s Approval in China?

Goldman Sachs recently initiated coverage on Keymed Biosciences, highlighting the approval of its first commercial product, stapokibart, in China for atopic dermatitis and chronic rhinosinusitis, while expressing confidence in the pipeline asset CM512 for asthma and COPD. This development underscores the growing recognition of Keymed's product pipeline and the confidence major institutions are placing in the company's future prospects. We'll explore how optimism for Keymed's pipeline,...
SEHK:1133
SEHK:1133Electrical

Will Harbin Electric's (SEHK:1133) Senior VP Appointment Signal a Shift in Operational Focus?

On October 27, 2025, Harbin Electric Company Limited announced the appointment of Mr. Chen Hui as senior vice-president, drawing on his leadership track record at China's leading hydropower and energy companies. Mr. Chen's blend of technical expertise and executive experience signals a potential shift toward strengthened operational capabilities and industry collaboration for Harbin Electric. We'll explore how Mr. Chen Hui's deep background in the energy sector may strengthen Harbin...
SEHK:175
SEHK:175Auto

Geely (SEHK:175) Valuation: Assessing Fair Value After 15% Revenue and 14% Net Income Growth

Geely Automobile Holdings (SEHK:175) has posted a 15% increase in annual revenue and a 14% rise in net income. This indicates progress in its operational performance. Investors are parsing these results as the company’s shares react in today’s trading. See our latest analysis for Geely Automobile Holdings. Geely’s share price has gained 24.7% so far this year, reflecting renewed optimism after a tough few weeks. Its 19.5% total shareholder return over the past year shows that long-term...